Showing results (1471-1480 of 5,493) with videos related to
Sort By:
Pageof 550
Pharmacotherapy|April 14, 2012
Indacaterol: a novel long-acting β(2) -agonistShaunta' M Ray, James C McMillen, Sarah A Treadway, et al.Pharmacotherapy|March 31, 2012
Vitamin D supplementation: what's known, what to do, and what's neededStuart T Haines, Sharon K ParkPharmacotherapy|April 1, 2011
Brand name versus generic warfarin: a systematic review of the literatureFrancesco Dentali, Marco P Donadini, Nathan Clark, et al.Pharmacotherapy|April 1, 2011
Changing oral contraceptives from prescription to over-the-counter status: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical PharmacyJennifer McIntosh, Sally Rafie, Mitzi Wasik, et al.Pharmacotherapy|September 20, 2011
Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic modelMarc H Scheetz, Maureen K Bolon, John S Esterly, et al.Pharmacotherapy|September 20, 2011
Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysisAndrea J Kellermann, Charlotte KloftPharmacotherapy|September 20, 2011
Enteral fish oil for treatment of parenteral nutrition-associated liver disease in six infants with short-bowel syndromeEmma M Tillman, Catherine M Crill, Dennis D Black, et al.Pharmacotherapy|September 20, 2011
Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centersAmy Pakyz, Norman V Carroll, Spencer E Harpe, et al.Pharmacotherapy|September 20, 2011
Effects of paroxetine on the pharmacokinetics and pharmacodynamics of immediate-release and extended-release metoprololRobert B Parker, Judith E SobermanPharmacotherapy|September 20, 2011
Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapyRachel N King, Stephanie L LagerPageof 550